not tagged
abbvie
['cll', 'abbvie']
today, at #eha2022, we announced five-year follow-up data from a phase 3 study in cll patients: 
AbbVie's global handle featuring biopharmaceutical news & updates managed by our corp digital team. Review our guidelines: https://t.co/RJsgPRX3Cb…